{"id":3250,"date":"2026-09-09T10:39:00","date_gmt":"2026-09-09T09:39:00","guid":{"rendered":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/?page_id=3250"},"modified":"2026-09-09T10:48:10","modified_gmt":"2026-09-09T09:48:10","slug":"prospect-express","status":"publish","type":"page","link":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/prospect-express\/","title":{"rendered":"PROSPECT-ExPRESS"},"content":{"rendered":"\n
<\/div>
<\/div><\/div>
\n

The Early Assessment, Diagnosis and Treatment of Parkinson’s Plus Related Syndromes (ExPRESS)<\/h1>\n\n\n\n

PROSPECT-ExPRESS: Improving early diagnosis and treatment of parkinsonism and related conditions<\/h3>\n<\/div><\/div><\/div><\/div><\/div>\n\n\n\n
\n
\"UCL<\/figure>
\n

Project Details<\/strong><\/p>\n\n\n\n

Start Date
Late 2026<\/strong><\/p>\n\n\n\n

Status
Site in Setup<\/strong><\/p>\n\n\n\n

Principal Investigator
Gordon Duncan<\/a><\/p>\n\n\n\n

NDN Study Lead
Bev Goldberg<\/a><\/p>\n\n\n\n

Main Research Site
Royal Infirmary of Edinburgh<\/strong><\/p>\n<\/div><\/div>\n\n\n\n

This research study aims to make it faster and more accurate to diagnose and predict how progressive supranuclear palsy, cortico-basal degeneration, multiple system atrophy and Parkinson\u2019s disease may develop.<\/p>\n\n\n\n

What Happens In This Study?<\/strong><\/p>\n\n\n\n

People in this study will have blood samples taken and complete questionnaires.<\/p>\n\n\n\n

Can I Join This Study?<\/strong><\/p>\n\n\n\n

To take part in this medical trial, you must meet these 6 requirements<\/strong>:<\/p>\n\n\n\n

    \n
  1. Your Diagnosis:<\/strong> You do not need to have a diagnosis to take part.<\/li>\n\n\n\n
  2. Your Age:<\/strong> You are 18 years or older<\/strong>.<\/li>\n\n\n\n
  3. Your Symptoms:<\/strong> You must have been seen at the hospital within the last year<\/strong> because of symptoms linked to Parkinson\u2019s disease<\/li>\n\n\n\n
  4. Your Study Partner:<\/strong> You must have a reliable friend of family member<\/strong> who knows you well and you see regularly, who can also take part to provide us with information on how you are doing.<\/li>\n\n\n\n
  5. Your Permission:<\/strong> You must be able to understand what happens in the study and sign a form (called informed consent<\/strong>) to say you agree to join.<\/li>\n\n\n\n
  6. Your Time:<\/strong> You must do your best to attend all your study visits, and follow the rules of the study until it ends.<\/li>\n<\/ol>\n\n\n\n

    Study Length<\/strong>: 48 months (4 years)<\/p>\n\n\n\n

    Number of appointments<\/strong>: 6 visits<\/p>\n\n\n\n

    More information on the trial can be found on the UCL Website<\/a>.<\/p>\n<\/div><\/div>\n\n\n\n

    Meet the Study Team<\/h2>
    \n
    \n
    \n

    NDN Principal Investigator: <\/strong>Gordon Duncan<\/p>\n\n\n

    \n
    \"\"<\/a>
    Consultant Physician & Lothian Clinical Lead
    <\/figcaption><\/figure>\n<\/div><\/div>\n\n\n\n
    \n

    NDN Study Lead: <\/strong><\/strong>Bev Goldberg<\/p>\n\n\n

    \n
    \"\"<\/a>
    Clinical Studies Officer<\/figcaption><\/figure>\n<\/div><\/div>\n<\/div>\n\n\n\n

    To find out more about this research study, please contact:
    loth.sdcrn@nhs.scot<\/a>
    0131 537 3804<\/strong><\/strong><\/p>\n<\/div><\/div>\n\n\n\n

    Funding and Sponsors<\/h2>
    \n
    \n
    \n
    \"UCL<\/a><\/figure>\n<\/div><\/div>\n\n\n\n
    \n
    \"NIHR\"<\/a><\/figure>\n<\/div><\/div>\n\n\n\n
    \n
    \"MRC\"<\/a><\/figure>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n
    <\/div>
    <\/div><\/div>
    \n
    \n
    \n
    \n

    CONTACT INFORMATION<\/strong><\/p>\n\n\n\n

    Neuroprogressive & Dementia Research Network Office<\/p>\n\n\n\n

    Old Pharmacy Building
    Western General Hospital
    Edinburgh
    EH4 2XU<\/p>\n\n\n\n

    Email: loth.sdcrn@nhs.scot<\/a><\/p>\n\n\n\n

    Telephone: 0131 537 3804<\/strong><\/p>\n<\/div>\n\n\n\n

    \n

    ABOUT US<\/strong><\/p>\n\n\n\n

    The NRS Neuroprogressive Disease and Dementia Network team in NHS Lothian conduct commercial and investigator led studies for: Alzheimers disease, Parkinsons disease, Huntingtons disease, Motor Neurone Disease, dementia with Lewy bodies, Progressive Supranuclear Palsy and Multiple System Atrophy.<\/p>\n\n\n\n

    <\/p>\n\n\n\n

    \u00a9 NHS LOTHIAN | YOUR SERVICE.<\/strong><\/sub><\/p>\n<\/div>\n<\/div>\n<\/div><\/div>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"

    Project Details Start DateLate 2026 StatusSite in Setup Principal InvestigatorGordon Duncan NDN Study Lead Bev Goldberg Main Research SiteRoyal Infirmary of Edinburgh This research study aims to make it faster and more accurate to diagnose and predict how progressive supranuclear palsy, cortico-basal degeneration, multiple system atrophy and Parkinson’s disease may develop. What Happens In This<\/p>\n","protected":false},"author":511,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_gspb_post_css":"","footnotes":""},"categories":[],"class_list":["post-3250","page","type-page","status-publish","hentry"],"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"jessicacrossan","author_link":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/author\/jessicacrossan\/"},"rttpg_comment":0,"rttpg_category":false,"rttpg_excerpt":"Project Details Start DateLate 2026 StatusSite in Setup Principal InvestigatorGordon Duncan NDN Study Lead Bev Goldberg Main Research SiteRoyal Infirmary of Edinburgh This research study aims to make it faster and more accurate to diagnose and predict how progressive supranuclear palsy, cortico-basal degeneration, multiple system atrophy and Parkinson’s disease may develop. What Happens In This","_links":{"self":[{"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/pages\/3250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/comments?post=3250"}],"version-history":[{"count":3,"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/pages\/3250\/revisions"}],"predecessor-version":[{"id":3265,"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/pages\/3250\/revisions\/3265"}],"wp:attachment":[{"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/media?parent=3250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/categories?post=3250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}